Chwee Foon Lim
About Chwee Foon Lim
Chwee Foon Lim is the CEO of Asia Pacific at Ekso Bionics, where she has worked since 2017. With over 20 years of experience in the Healthcare and Life Science sector, she has held significant leadership roles at companies like ExxonMobil and The Linde Group.
Work at Ekso Bionics
Chwee Foon Lim has served as the CEO for the Asia Pacific region at Ekso Bionics since 2017. In this role, she has led the market entry and transformation of the industry through the introduction of innovative robotics technology. Her leadership has contributed to the company's growth and expansion in the healthcare sector, particularly in the application of robotic solutions.
Education and Expertise
Chwee Foon Lim holds a Bachelor's degree in Accountancy from the National University of Singapore. She furthered her education at INSEAD, where she achieved an MBA and was recognized on the Dean's list. Her academic background supports her extensive expertise in business innovation, sustainability, and digital transformation, which she imparts through teaching multiple Executive MBA courses at INSEAD.
Background
Chwee Foon Lim has over 20 years of international experience in the Healthcare and Life Science sector. She has held significant roles in various organizations, including as Operations & Planning Manager at ExxonMobil and as Audit Manager at Arthur Anderson. Her tenure at The Linde Group spanned 16 years, where she was the Head of Asia Pacific, Healthcare, and played a key role in building a national healthcare business in China.
Achievements
Throughout her career, Chwee Foon Lim has demonstrated a strong track record of driving business transformation and leading start-ups with a focus on robotics and digitalization. She has held global leadership roles at Syngenta and Linde, concentrating on strategy, mergers and acquisitions, and business turnaround initiatives in Europe and the USA. Additionally, she is a passionate advocate for diversity, equity, and inclusion.
Professional Affiliations
Chwee Foon Lim serves as a Global Board Member at INSEAD since 2022, where she contributes to governance and oversight as a member of the Audit and Risk Committee. She regularly shares her insights and expertise at various medical technology forums, enhancing her professional network and influence in the industry.